Page last updated: 2024-11-05

tolbutamide and Bile Duct Cancer

tolbutamide has been researched along with Bile Duct Cancer in 2 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BERKOWITZ, D1
Erwald, R1
Hed, R1
Nygren, A1
Röjdmark, S1
Sundblad, L1
Wiechel, KL1

Other Studies

2 other studies available for tolbutamide and Bile Duct Cancer

ArticleYear
PITFALLS IN THE DIFFERENTIAL DIAGNOSIS OF JAUNDICE.
    The American journal of gastroenterology, 1964, Volume: 41

    Topics: Alkaline Phosphatase; Anemia; Anemia, Hemolytic; Bile Duct Neoplasms; Blood Chemical Analysis; Diagn

1964
Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration.
    Diabetes, 1971, Volume: 20, Issue:10

    Topics: Adult; Aged; Alanine Transaminase; Alcoholism; Alkaline Phosphatase; Antigen-Antibody Reactions; Asp

1971